Carefully chosen, elevated-conviction firm that writes $25–75M initial checks to ~15 businesses, makes elevated-conviction bets (e.g., ~40% of $50M toward Coupang returning ~$8B), alongside partners long-term while holding public equity.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Selective firm investing where it has an unfair advantage, running a company-creation platform with 22 EIRs and a 90+ C-suite council delivering market insights to healthcare, data+AI and cyber defense. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Series B investor (~$15M checks) acting as venture coaches—former Twitter, Google, and Facebook execs who avoid board seats and support founders build sales organizations and revenue operations. The firm continues to build its presence across the venture capital landscape.
Targets hard, capital‑intensive sustainability technologies other VCs avoid, bridging solutions from developed markets into China and developing countries (energy, food, health, environment) to build traction back into developed markets. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
As a venture investment firm headquartered in New York City, 212.VC has built a distinct presence in its market. Launched in 2011, the fund is dedicated to nascent-stage investments in technology companies in the East Coast and Europe. The organization's investments are centered on technology companies in the areas of e-commerce, mobile, advertising, and digital media. In addition, group also extends additional support to their invested companies through mentorship, resources, and access to the 212.VC network. 212.VC has deployed capital into over 100 companies and has exited investments in companies such as Uber, Houzz, and Warby Parker.
A Los Angeles-based venture fund and startup studio where Spencer Rascoff directly incubates proptech and future-of-living nascent-stage companies, providing media-driven exposure, co-creation expertise, and public-market/SPAC experience. The firm continues to build its presence across the venture capital landscape.
Is dedicated to companies empowering informed, connected health consumers and building system-level resilience to improve outcomes, experiences, and lower healthcare costs. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
